Elon Musk Plans to File Counter-lawsuit Against Twitter
-NY Post
https://nypost.com/2022/07/18/elon-musk-to-countersue-twitter-in-attempt-to-scrap-44b-buyout/
Hearing Second Sight Medical Products To Be Issued U.S. Patent On July 19, 2022 Titled ‘FACE DETECTION TRACKING AND RECOGNITION FOR A VISUAL PROSTHESIS’
https://twitter.com/PatentGrants/status/1549049927614902273
‘$NFLX $MSFT partnering for ad supported service’ -Tweet From Fast Stock Market News
https://twitter.com/faststocknewss/status/1547287336387428353?s=20&t=zuo4Dgkvh9wKrGHjqdRpWA
The Daily Biotech Pulse: Merck’s Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill
Here's a roundup of top developments in the biotech space over the last 24 hours:
Report Twitter is Working on in-app Podcast Player
https://twitter.com/wongmjane/status/1544981108823310336
NY Post Reported on Sunday Rumored Merger Talks Between Cushman & Wakefield and Newmark
https://nypost.com/2022/06/26/merger-whispers-between-cushman-and-newmark-reignite-at-rebny-gala/
Apple’s Expected New 15-Inch Macbook: What We Know So Far
Apple Inc (NASDAQ: AAPL) has long been rumored to launch a larger version of its Macbook Air. In this article, we will review all that we know about this upcoming device.
SVB Leerink’s Pro-forma Analysis Of Speculated Merck/Seagen Deal – What Investors Need To Know
SVB Securities conducted a pro-forma analysis of the financial impact to Merck & Co Inc (NYSE: MRK) from a potential acquisition of Seagen Inc (NASDAQ: SGEN).
Elon Musk Being Sued For $258B Over Alleged Dogecoin Manipulation: The Rise And Fall Of The Famous Meme Coin
In Manhattan yesterday (6/16/22), a class-action lawsuit was filed against Tesla Inc (NASADAQ: TSLA) CEO Elon Musk, by a man named Keith Johnson. The accusation is that Musk, Tesla, and SpaceX are operating an illegal racketeering enterprise to inflate the price of Dogecoin (CRYPTO: